Future Fund LLC’s RxSight RXST Stock Holding History

Future Fund LLC’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-74,406	Closed	-$669K	–	174
2025 Q3	$669K	Buy	74,406 +27,657	+59%	+$243K	0.24%	149
2025 Q2	$608K	Buy	+46,749	New	+$703K	0.27%	145

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Future Fund LLC's RXST Position: Q4 2025 in Review

Future Fund LLC sold out of RxSight (RXST) in Q4 2025, closing a stake of 74,406 shares — an estimated $669K sold.

Future Fund LLC first reported a position in RXST in Q2 2025 and held it in 2 quarters. The position peaked at $669K in Q3 2025. 163 funds tracked by Wall St. Rank hold RXST as of Q4 2025.

Future Fund LLC reported no remaining RxSight position as of Q4 2025 after selling out during the quarter.
Future Fund LLC sold 74,406 RxSight shares in Q4 2025, an estimated $669K.
Future Fund LLC first reported a position in RxSight in Q2 2025 and held it in 2 quarters.
Future Fund LLC's RxSight position peaked at $669K in Q3 2025.
163 funds tracked by Wall St. Rank held RxSight as of Q4 2025.

Based on Future Fund LLC's 13F filing for Q4 2025, filed 10 Feb 2026.